Private Equity

In a landmark decision, Jack Daniel's rare 14-year-old whiskey beat elite rivals in a blind tasting to claim the top honor from influential Bourbon Podcast.

Capstone Accounting's acquisition of North Star signals a major shift in Washington's local market, reflecting a national trend of industry consolidation.

With industry veteran Kevin Muskat at the helm, Leon Capital Group's new advisory practice promises M&A guidance free from audit firm conflicts.

Biotech pioneer Dr. Patrick Soon-Shiong is named a top influencer in oncology, boosting ImmunityBio amid strong sales and a promising drug pipeline.

Kiely Family of Companies jumps 48 spots on the ENR Top 600 list, a success story fueled by strategic growth and America's urgent need for infrastructure.

Capital Clean Energy Carriers Corp. orders three advanced LNG carriers, positioning itself to capitalize on a projected surge in global gas demand.

He helped land a Bible on the moon, but his final years were spent in state custody as his historic legacy became trapped in a bitter legal battle.

A seven-year investment in a Virginia apartment complex yields a 24% IRR, showcasing the power of patient capital and strategic renovations.

Branded Legacy just wiped out $1M in legacy debt. The move is part of a radical overhaul by new management aimed at rebuilding investor confidence.

SoftBank is buying digital infrastructure giant DigitalBridge for $4B, a bold move to own the data centers and fiber needed to power its AI ambitions.

Setrusumab, a promising drug for Osteogenesis Imperfecta, failed to reduce fractures in key trials, triggering a market collapse and strategic overhaul.

A pivotal trial for an acute myeloid leukemia drug is delayed for a promising reason: patients are surviving longer than anticipated, fueling cautious optimism.

Fresh off a volatile IPO, Malaysian hotpot chain CCH Holdings plans a massive 2026 expansion. Can this small-cap company conquer the U.S. and Africa?

In a bold strategic shift, private jet operator Volato is entering the national security-focused critical minerals sector, guided by a seasoned financier.

As 374Water pushes its waste-destroying tech to market, a new board member with deep financial expertise and a history as a long-term investor joins.

The cleantech firm hits key milestones in German and Italian energy projects while its unconventional portfolio expands into biotech and agritech.

Azenta divests its medical refrigeration unit to streamline its portfolio, signaling a strategic pivot to its high-growth multiomics and sample management services.

Chinese cloud firm Cloopen forms a special committee to eye a go-private deal from its own CEO, putting shareholder value and corporate governance in the spotlight.

A new partnership with logistics giant Uniphar will bring Zevra's breakthrough NPC therapy, MIPLYFFA, to patients in underserved regions worldwide.

After a turbulent year, the sleep apnea device maker aims to prove its rocky product launch is behind it and convince investors of a strong 2026.